CardioDx Data Presented on Prevencio Coronary Artery Disease Panel as Firm Targets FDA Submission Premium The developer has presented clinical results that provide a base for completing development of a multi-protein test kit and conducting a clinical trial in advance of FDA submission. CardioDx Raises $20M; Inks Specimen Draw Agreement With Quest The deal with Quest enables clinicians to order blood draws on patients through its facilities for testing with CardioDx's Corus CAD test. CardioDX Presents Corus CAD Utility Data in Women; Focuses on Sex Differences Education Premium The data, presented at the American College of Cardiology meeting, showed that doctors referred only 4 percent of women with low Corus CAD scores for further cardiac evaluation. CardioDx Withdraws IPO In an SEC document, the company called current market conditions for an IPO unattractive. CardioDx Raises $35M The financing will go toward further commercialization of its Corus CAD test, as well as other genomics tests for coronary artery disease. Oct 22, 2014 CardioDx Shares Data from Utility Study Highlighting Benefits for African-American Population Premium Aug 7, 2014 DxTerity Diagnostics Launches Sample Collection and Assay Kits; Aims to Drive Down LDT Costs Premium Jul 25, 2014 Awaiting IPO, CardioDx Raises $21M in Private Financing Jul 7, 2014 Aetna Begins Coverage of CardioDx's Coronary Artery Disease Test May 1, 2014 People in the News: Changes to Hologic Management; New Hires, Board Members at CareDx, CardioDx Premium Apr 29, 2014 CardioDx 2013 Revenues Rise Sharply Apr 9, 2014 Medison to Market CardioDx's Corus CAD in Israel Apr 2, 2014 Prospective Study Adds to Utility Evidence for CardioDx's Corus CAD Rule-out Test Premium Nov 4, 2013 CardioDx Sets Price Range on Planned IPO Oct 28, 2013 Awaiting IPO, CardioDx Q3 Revenues up Sharply Oct 23, 2013 MDx/CDx Focus: Study Data on Corus CAD; Clovis, Qiagen Partnership Premium Oct 14, 2013 Cardiovascular MDx Firm CardioDx Files to Go Public May 9, 2013 CAP Accredits CardioDx's Laboratory Apr 25, 2013 CardioDx, Core Diagnostics India Reach Agreement to Offer CAD Test in India Mar 20, 2013 CardioDx Data Suggests Corus CAD May Reduce Additional Testing in Women at Low Risk of CAD Premium Feb 13, 2013 Amid 'Chaos,' FDA's Gutierrez Offers Insights on Agency's Regulatory Stance on Molecular Tests Premium Nov 28, 2012 MDx/CDx Focus: CardioDx's Corus CAD in Heart Study; EMA Filing for Vintafolide; Transrenal KRAS Test Premium Nov 27, 2012 CardioDx Joins Duke, NHLBI Coronary Artery Disease Research Effort Sep 26, 2012 CardioDx Continues Adoption, Coverage Push for Corus CAD Premium Aug 29, 2012 CardioDx Says $58M Financing Will Support Commercial Expansion Following Medicare Coverage Win Premium Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.